By targeting GIP, GLP-1, and glucagon receptors, the investigational triple agonist could mark the next evolution in incretin ...

Amylin-based petrelintide has achieved good results at Phase II for obesity, showing 8-11% weight loss and a good side effect profile.

Just a small amount of recorded speech could identify type 2 diabetes using an AI-based screening tool, research presented at a scientific conference suggests.

Kodiak's eye drug Zenkuda edges towards approval after another successful Phase III trial in wet AMD adds to other successful ...

Researchers developed ChromAgeNet, an AI tool that detects age-related chromatin changes in blood stem cells from 3D ...

Reducing reliance on ultracold storage could lower costs, limit vaccine waste, and expand access to mRNA vaccines and other ...

Early treatment is key, as heart and kidney problems increase significantly with time for people with type 2 diabetes.

A blood test may help doctors assess babies with fever to identify the most serious bacterial infections that require antibiotics.

Blood protein changes during lecanemab treatment could offer a less invasive way to track and understand Alzheimer’s ...

Experts debate the evidence, uncertainties, and readiness for widespread use of GRAIL’s Galleri multicancer early detection ...

Transforming one-off therapies into accessible and repeatable programs requires early strategy and shared infrastructure.